𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Experience with sunitinib in hormone-resistant metastatic prostate cancer that is unresponsive to docetaxel

✍ Scribed by J.M. Gasent; E. Grande; J. Casinello; M. Provencio; J.B. Laforga; V. Alberola

Book ID
119648933
Publisher
Elsevier
Year
2011
Weight
301 KB
Volume
35
Category
Article
ISSN
2173-5786

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase 2 study of carboplatin plus doce
A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel
✍ Robert W. Ross; Tomasz M. Beer; Susanna Jacobus; Glenn J. Bubley; Mary-Ellen Tap πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 79 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Prostate cancer is the second leading cause of cancer mortality among men in the U.S. To the authors' knowledge, there is no proven, effective, second‐line therapy for docetaxel‐refractory disease. Recent data suggest that platinum salts may be effective when combined wi